Overview

LEADERS FREE II: BioFreedom™ Pivotal Study

Status:
Active, not recruiting

Trial end date:
2021-03-01

Target enrollment:

Participant gender:

Summary

This study aims to confirm non-inferiority of the BioFreedom™ Drug Coated Stent to the Gazelle™ Bare Metal Stent arm of the Leaders Free study (NCT01623180) in high bleeding risk patients.

Phase:

N/A

Details

Lead Sponsor:

Biosensors Europe SA

Treatments:

Platelet Aggregation Inhibitors